Trial Profile
A study investigating effect of belatacept in patients with kidney transplant who were receiving calcineurin inhibitors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 18 Aug 2015 New trial record